Stanford researchers have developed EphrinA3 technology to strengthen epithelial barriers by increasing expression of cell-cell adhesion molecules, particularly desmoglein-1 (DSG1) and desmocollin-1 (DSC1).
Diagnosis and sub-typing of inflammatory bowel disease (IBD) subsets, such as Crohn's disease (CD) and ulcerative colitis (UC), often require the use of repeated, invasive, and expensive endoscopy procedures, which are not without risk.
Stanford researchers have developed a general system to regulate the activities of specific proteins in mammalian cells using cell-permeable, synthetic molecules.
The Stanford team developed a groundbreaking approach to measure single molecules by precisely measuring the forces induced by the absorption of electromagnetic radiation.
Stanford researchers in the Onori Lab have developed a method for accurately estimating battery state-of-charge (SOC) using the inverse derivative of galvanostatic voltage response (dQ/dV) curve.
Stanford researchers in the Onori Lab have developed a battery management system (BMS) that uses sine-wave current pulses to accurately determine a battery's state-of-charge (SOC).
Stanford scientists have developed Plate-C, a high-throughput screening platform that captures genome-wide 3D chromatin architecture as a comprehensive cellular phenotype.
Stanford researchers have developed a technology for the automated separation of arteries and veins in single-phase brain CT angiography (CTA) using graph neural networks, enabling precise collateral scoring and improved stroke prognosis.
Stanford researchers have developed a novel technology called FLASH (Functional Assigning Sequence Homing) that predicts phenotypes directly from raw sequencing data, bypassing assembly and alignment, while revealing the biological features driving those predictions.
Researchers at Stanford in collaboration with researchers at NYU have identified novel epitopes on Lymphocyte activation gene-3 (LAG-3) that regulate T cell activation. Blocking those LAG-3 epitopes has potential as a novel immune checkpoint inhibitor therapy.
Stanford scientists have developed a parametrically programmable delay line that uses superconducting circuits to store and manipulate quantum information with dynamic control capabilities.
Researchers in Professor Justin Sonnenburg's laboratory have developed genetic tools for manipulating Bacteroides, a prominent genus of gut bacteria, for imaging, diagnostics, and therapeutic drug delivery.